American board of infectious diseases

<p><strong>Domain 1: Patient Care and Therapeutics (about 50% of the exam):</strong></p> <ol> <li>Pathophysiology and epidemiology of infections including: Bone and joint infections - Cardiovascular

  • American board of infectious diseases

Course Overview

Domain 1: Patient Care and Therapeutics (about 50% of the exam):

  1. Pathophysiology and epidemiology of infections including: Bone and joint infections - Cardiovascular infections - Central nervous system infections - Gastrointestinal infections - HIV-infection and AIDS (including opportunistic infections) - Infections of reproductive organs - Intra-abdominal infections - Lower respiratory tract infections - Ophthalmologic infections - Sepsis - Sexually transmitted diseases - Skin and soft tissue infections - Tuberculosis and other mycobacterial infections - Upper respiratory tract infections - Urinary tract infections -Viral hepatitis
  2. Pharmacotherapies related to specific infectious diseases (e.g.,bacterial, fungal, viral)
  3. Pharmacokinetics and pharmacodynamics of antimicrobials (e.g. anti-fungals)
  4. Pharmacology of antimicrobials
  5. Pharmacology of vaccines
  6. Pharmacology of biological response modifiers (e.g., TNF inhibitors, colony stimulating factors) Mechanisms of pathogen resistance
  7. Antimicrobial drug interactions
  8. Complications of antimicrobials
  9. Complications of vaccines
  10. Spectrum of activity of antimicrobials
  11. Structure and characteristics of pathogenic microorganisms
  12. Basic microbiology laboratory procedures
  13. Clinical laboratory tests in ID (e.g., rapid diagnostic testing, RPR, antibody concentrations)
  14. Diagnostic and therapeutic procedures in ID (e.g., lumbar puncture, paracentesis)
  15. Factors that alter the risk of infection
  16. Immunologic response to infection
  17. Immunologic therapy (e.g., immunoglobulin, Mannose Binding Lectin)
  18. Outpatient parenteral antimicrobial therapy
  19. Therapeutic monitoring of antimicrobials
  20. Factors that may impact response to therapy (e.g., dose optimization, penetration of antimicrobials, source control, immune status)
  21. Antimicrobial de-escalation
  22. Measures to monitor response to antimicrobial therapy (e.g., resolution of signs and symptoms, laboratory data, readmission, development of drug resistance)
  23. Patient and caregiver education and counseling techniques
  24. Antimicrobial allergy and cross-reactivity
  25. Antimicrobial desensitization
  26. Preventive therapies (e.g., infection prophylaxis, vaccines, behavior modification)
  27. Factors to consider when differentiating infection from non-infection
  28. Considerations in special populations (e.g., geriatrics, pediatrics, obesity)
  29. Facilitation across transitions of care
  30. Considerations in drug delivery

Domain 2: Education, Research and Scholarship (about 20% of the exam):

  1. Principles and methods of educating, training and mentoring pharmacists, pharmacy students, residents and fellows.
  2. Principles and methods of educating and communicating with other healthcare professionals
  3. Appropriate resources for infectious disease information
  4. Research study design and methodology, including those specific to ID (e.g., Monte Carlo simulation, microbiologic surveillance, time-kill)
  5. Statistical methods
  6. Clinical application and limitations of published data and reports
  7. Regulatory and ethical issues related to conducting research
  8. Venues and processes for disseminating knowledge (e.g., audience-specific medical writing, publication, presentation)
  9. Mechanisms for continuing professional development in ID pharmacy

 

Domain 3: Antimicrobial Stewardship and Practice Management (about 25% of the exam):

  1. Antibiogram design and development
  2. Antimicrobial stewardship strategies
  3. Antimicrobial resistance trends
  4. Metrics for antimicrobial use
  5. Clinical practice guidelines for ID (e.g., IDSA, SHEA, CDC)
  6. Methods for developing and evaluating clinical practice guidelines
  7. Infection control and prevention strategies
  8. Metrics for infection control
  9. National accreditation and regulatory organizations and requirements (e.g., Joint Commission, CMS, NHSN)
  10. Quality improvement strategies (e.g., MUE, FMEA, root cause analysis)
  11. Roles of infection control and prevention, microbiology and ID divisions/departments
  12. Collaboration strategies and consensus building
  13. Metrics for evaluating value of ID pharmacy services
  14. Pharmacoeconomic assessment of antimicrobials

Domain 4: Public Health and Advocacy (about 5% of the exam)

  1. Public health information resources related to infectious diseases
  2. Public health services related to infectious diseases
  3. CDC notifiable infectious diseases
  4. Populations at risk for infection
  5. ACIP immunization recommendations and schedules
  6. Strategies for advocating vaccination and prudent antimicrobial use
  7. Professional organizations and their roles and resources related to patient advocacy (e.g., Immunization Action Coalition, IDSA, ASHP, APhA, SIDP)
  8. Screening guidelines for infectious diseases (e.g. HIV, STDs, tuberculosis)
  9. Agents that have the potential to become epidemic or pandemic
  10. Emerging infectious diseases
  11. History of vaccine preventable diseases

بعد الإعلان لأول مرة عن تخصص الصيدلة الإكلينيكية فى مجال علاجيات الأمراض المعدية من البورد الامريكى للصيدلة الإكلينيكية BPS  فى بداية 2018...إحجز مكانك الان فى أول مجموعة دراسية فى العالم العربى للتاهيل للحصول على البورد الأمريكى لعلاجيات الأمراض المعدية و كن من أوائل حاملى هذه الشهادة فى العالم.

Look at Our Latest Courses

You Can Suggest a New Course